|
|
|
|
|
Updates in CLL: A Closer Look at Adverse Events
|
|
|
Thursday, September 9, 2021 • 7:00pm – 8:00pm ET
|
|
|
|
|
Carrie Lenneman, MD, MSCI
Associate Professor
University of Alabama Birmingham
|
|
|
|
Farrukh Awan, MD
Associate Professor, Department of Internal Medicine
UT Southwestern Medical Center
|
|
|
|
Objectives:
- Review the role of BTKi in the management of chronic lymphocytic leukemia (CLL)
- Take an in-depth look at adverse events associated with BTKi with a focus on cardiotoxicity
- Obtain insight on strategies for monitoring and management and the potential impact on subsequent therapy selection
- Discuss the role of advanced practice practitioners, nurses, and other medical professionals in the care of patients with CLL
|
|
|
|
|
|
|
|
|
|
